The Living Donor Protection Act of 2025 makes it unlawful for insurers to deny, cancel, refuse to issue, or charge higher premiums on the basis that an applicant or policyholder is a living organ donor—unless the insurer can point to an actual, unique, and material actuarial risk tied to donation. The prohibition covers life insurance, disability insurance, and qualified long-term care insurance.
The bill also amends the Family and Medical Leave Act (and parallel federal civil service rules) to explicitly count recovery from organ-donation surgery as a serious health condition, lets certain federal employees substitute other leave while serving as a donor, and directs HHS to update public education materials within six months to describe risks, benefits, and the new legal protections. For insurers, state regulators, employers, and transplant programs, the measure changes underwriting, enforcement, and public messaging around living donation.
At a Glance
What It Does
The bill prohibits insurers from treating living organ donor status as a basis to deny coverage or change premiums for life, disability, and specified long-term care policies, unless there is demonstrable, donor-specific actuarial risk. It amends FMLA definitions to include recovery from organ-donation surgery and requires HHS to refresh public materials within six months.
Who It Affects
Life, disability, and long-term care insurers and their underwriters; state insurance regulators charged with enforcement; private-sector and federal employees who donate organs; transplant centers and patient-education programs that work with donors.
Why It Matters
This creates an explicit federal floor protecting living donors from insurance-based disincentives, clarifies leave rights for donor recovery, and pushes the federal government to update outreach—measures likely to affect underwriting practices, regulator actions, and donor recruitment efforts.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Section 2 sets a firm bar: insurers may not deny coverage, cancel, refuse to issue, or vary the price or any other term of a life, disability, or qualified long-term care insurance policy solely because someone is a living organ donor. The bill conditions that bar on the absence of any ‘‘actual, unique, and material actuarial risks’’ tied to donor status—putting the burden on insurers to show a donor-specific risk that meaningfully affects pricing or eligibility.
The statute supplies short definitions of the three covered policy types and of ‘‘living organ donor’’ (any person who donated all or part of an organ and is not deceased), so the protection reaches past donors as well as recent ones.
Enforcement is left to state insurance regulators: the bill says a State insurance regulator may take such actions to enforce the prohibition as are specifically authorized under that State’s law. The measure does not create a federal private right of action, nor does it lay out federal penalties or a federal enforcement mechanism.
That design places emphasis on state-level regulation and existing supervisory tools to police underwriting and rates.Section 3 amends the Family and Medical Leave Act’s definition of ‘‘serious health condition’’ to explicitly include recovery from surgery related to organ donation for private-sector employees. Parallel changes apply to the federal civil service definition.
For federal employees, the bill also permits an employee who uses part of the 12‑week leave entitlement to serve as an organ donor to elect to substitute leave available under 5 U.S.C. 6327 for as much of that period as possible—effectively allowing use of other earned leave to cover donor recovery while preserving FMLA leave protections.Section 4 requires the Secretary of Health and Human Services to review and update public materials on living donation within six months. That update must cover both the clinical benefits and risks of donation and the new insurance and leave protections in the Act.
HHS is directed to refresh public service announcements, organdonor.gov (or its successor), and other media as appropriate, which institutionalizes a federal education effort tied directly to the statutory changes and may affect donor outreach and counseling practices at transplant centers.
The Five Things You Need to Know
The bill bars insurers from denying coverage, canceling policies, refusing to issue, or varying price or other terms for life, disability, or qualified long-term care policies solely because an individual is a living organ donor, unless the insurer demonstrates an actual, unique, and material actuarial risk tied to donation.
Definitions are explicit: a living organ donor is any person who has donated all or part of an organ and is not deceased; life, disability, and long-term care policies are narrowly defined in the statute.
Enforcement is delegated to state insurance regulators—there is no federal private right of action or federal enforcement penalty set out in the bill.
The bill amends the FMLA (private sector) and federal civil service law to treat recovery from organ-donation surgery as a ‘‘serious health condition’’ and allows certain federal employees to substitute other leave under 5 U.S.C. 6327 for donor-related absence.
HHS must review and update public educational materials about living donation within six months, including information about the Act’s insurance and leave protections and updates to organdonor.gov and related outreach channels.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Establishes the Act’s name as the "Living Donor Protection Act of 2025." This is a technical provision but signals the bill’s focus on donor protections and frames subsequent references to the statute.
Insurance nondiscrimination rule and definitions
Subsection (a) creates the substantive prohibition on insurer actions—denying, canceling, refusing to issue, or varying premiums or other terms—based solely on living donor status. It includes a limiting standard: insurers may take differential action only where there are ‘‘actual, unique, and material actuarial risks’’ associated with donation, which requires insurers to link any underwriting differential to verifiable actuarial evidence. Subsection (c) supplies concise statutory definitions of the covered policy types and of ‘‘living organ donor,’’ which clarifies scope for both current and past donors and narrows the covered insurance products to life, disability, and long‑term care as defined in federal tax code cross-reference.
State enforcement responsibility
Rather than creating a federal enforcement mechanism, the bill authorizes State insurance regulators to enforce the prohibition using powers expressly provided under each State’s law. Practically, that means enforcement tools—rate reviews, market conduct exams, cease-and-desist orders, fines—depend on state statutes and regulations. The absence of a federal private cause of action or federal penalty scheme makes uniform enforcement contingent on state-level activity and priorities.
FMLA and federal civil service amendments for donor recovery
The bill amends the FMLA definition of ‘‘serious health condition’’ to expressly include recovery from organ-donation surgery, extending the statutory leave protection to donor recuperation for private-sector employees. For federal civil service employees, the bill makes a parallel definitional change and adds an explicit substitution rule: federal employees who take part of the 12‑week period for organ donation may elect to substitute leave available under 5 U.S.C. 6327 for as much of that period as possible. That substitution language affects how federal employees can preserve different leave pools while remaining protected by FMLA-style leave rights.
HHS review and public education update
Directs the Secretary of Health and Human Services to review and update living donation educational materials within six months, covering both clinical benefits/risks and the Act’s insurance and leave protections. The statute instructs HHS to refresh public service announcements, organdonor.gov (or successor), and other media as appropriate, which creates an administrative timeline and a designated communications channel for conveying the law’s practical impact to donors, clinicians, insurers, and employers.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Living organ donors (current and past) — The prohibition prevents insurers from using donor status alone to deny coverage or increase premiums for life, disability, or specified long‑term care products, reducing a documented barrier to donation.
- Transplant centers and donor advocates — By lowering insurance-related disincentives and requiring HHS outreach, the bill strengthens counseling tools and may ease donor recruitment and informed consent discussions.
- Employees who donate organs — The explicit FMLA inclusion for donor recovery ensures private-sector donors get protected leave; federal employees get an added option to substitute other leave to cover donor recovery time.
Who Bears the Cost
- Life, disability, and long-term care insurers — Insurers must adjust underwriting manuals, justify any donor-specific rating differences with actuarial proof, and potentially face increased regulatory scrutiny from state regulators.
- State insurance regulators — States must use their existing enforcement authorities to police compliance; that may increase market conduct exams, rate reviews, or administrative actions without additional federal funding.
- Employers and human resources operations — Employers will need to implement internal guidance to reflect FMLA changes, train staff on donor leave handling, and coordinate with federal leave substitution rules for civil service employees.
Key Issues
The Core Tension
The central dilemma is between removing insurance‑related disincentives to living organ donation and preserving insurers’ ability to set premiums based on verifiable actuarial risk: the bill protects donors from categorical treatment, but entrusts state regulators and actuarial proof to draw the line, risking uneven enforcement and insurer workarounds that could undercut the statute’s protective intent.
The statute’s ‘‘actual, unique, and material actuarial risks’’ standard is the practical hinge: it protects donors from categorical discrimination but preserves insurers’ ability to rely on actuarial evidence where donation demonstrably affects mortality or morbidity. The bill does not define what constitutes adequate actuarial proof or which methodologies suffice, leaving those contested determinations to regulators, actuaries, and potentially litigation at the state level.
Because enforcement rests with state regulators, outcomes may vary across jurisdictions depending on regulatory capacity, statutory tools, and willingness to challenge insurers’ underwriting models.
Other implementation questions are unresolved in the text. The Act does not create a federal private right of action, so individuals who believe they were discriminated against must rely on state enforcement mechanisms or state consumer remedies.
The interplay between this federal prohibition and state insurance rate-setting and actuarial standards could produce regulatory tension: states may interpret the bill’s not‑withstanding clause differently, and insurers may pivot to underwriting on health conditions associated with donation (instead of donor status per se), potentially producing similar practical effects unless regulators look through proxy variables. Finally, the requirement for HHS to update outreach within six months is explicit, but the bill provides no funding or standards for how those materials should address complex actuarial or underwriting concerns, leaving room for uneven guidance that could affect insurers’ and employers’ interpretations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.